Article
Commentary: HER2-Positive EGA, Immunotherapy With Chemoradiation, and Lymph Node Metastasis in GC, December 2022
- Author:
- Nataliya Uboha, MD, PhD
Publish date: November 29, 2022
Article
Commentary: Potential new treatments in gastroesophageal adenocarcinoma, November 2022
- Author:
- Nataliya Uboha, MD, PhD
Publish date: October 28, 2022
Article
Commentary: Biomarkers and Chemotherapy in Gastric Cancer, October 2022
- Author:
- Nataliya Uboha, MD, PhD
Publish date: September 30, 2022
Article
Commentary: Gastric Cancer Surgery Trials, September 2022
- Author:
- Nataliya Uboha, MD, PhD
Publish date: August 26, 2022
Article
Commentary: Treating Gastric Cancer Subtypes, August 2022
- Author:
- Nataliya Uboha, MD, PhD
Publish date: August 2, 2022
Article
Commentary: Ramucimumab, Napabucasin, and Pembrolizumab Trial Results, July 2022
- Author:
- Nataliya Uboha, MD, PhD
Publish date: July 1, 2022
Article
Commentary: Gastric Cancer Chemotherapy in Select Populations, June 2022
- Author:
- Nataliya Uboha, MD, PhD
Publish date: June 1, 2022